A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

George Rodrigues, Slav Yartsev, Keng Yeow Tay, Gregory R Pond, Frank Lagerwaard, Glenn Bauman

ABSTRACT

BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction with 30 Gy/10 fractions WBRT. Helical tomotherapy (HT) was found to be dosimetrically equivalent to SRS in terms of target coverage and superior to SRS in terms of normal tissue tolerance. A phase I trial has been now completed at our institution with a total of 60 enrolled patients and 48 evaluable patients. The phase II dose has been determined to be the final phase I cohort dose of 60 Gy/10 fractions. METHODS/DESIGN: The objective of this clinical trial is to subject the final phase I cohort dose to a phase II assessment of the endpoints of overall survival, intracranial control (ICC) and intralesional control (ILC). We hypothesize HT would be considered unsuitable for further study if the median OS for patients treated with the HT SIB technique is degraded by 2 months, or the intracranial progression-free rates (ICC and ILC) are inferior by 10% or greater compared to the expected results with treatment by whole brain plus SRS as defined by the RTOG randomized trial. A sample size of 93 patients was calculated based on these parameters as well as the statistical assumptions of alpha = 0.025 and beta = 0.1 due to multiple statistical testing. Secondary assessments of toxicity, health-related quality-of-life, cognitive changes, and tumor response are also integrated into this research protocol. DISCUSSION: To summarize, the purpose of this phase II trial is to assess this non-invasive alternative to SRS in terms of central nervous system (CNS) control when compared to SRS historical controls. A follow-up phase III trial may be required depending on the results of this trial in order to definitively assess non-inferiority/superiority of this approach. Ultimately, the purpose of this line of research is to provide patients with metastatic disease to the brain a shorter course, dose intense, non-invasive radiation treatment with equivalent or improved CNS control/survival and health-related quality-of-life/toxicity profile when compared to SRS radiotherapy. TRIAL REGISTRATION: Clinicaltrials.gov - NCT01543542. More... »

PAGES

42

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1748-717x-7-42

DOI

http://dx.doi.org/10.1186/1748-717x-7-42

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027926222

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22436144


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cranial Irradiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Division of Radiation Oncology, Department of Oncology, University of Western Ontario and London Regional Cancer Program, London Health Sciences Centre,University of Western Ontario and London Regional Cancer Program, N6A4L6, London, ON, Canada", 
            "Department of Epidemiology and Biostatistics, University of Western Ontario, N6A3K7, London, ON, Canada", 
            "790 Commissioners Rd. E, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rodrigues", 
        "givenName": "George", 
        "id": "sg:person.0676000441.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676000441.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Department of Medical Biophysics, University of Western Ontario, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yartsev", 
        "givenName": "Slav", 
        "id": "sg:person.01002230243.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002230243.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Medical Imaging, London Health Sciences Centre, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tay", 
        "givenName": "Keng Yeow", 
        "id": "sg:person.01252126745.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252126745.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McMaster University", 
          "id": "https://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Oncology, McMaster University and Escarpment Cancer Research Institute, L8V1C3, Hamilton, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pond", 
        "givenName": "Gregory R", 
        "id": "sg:person.01251570265.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251570265.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081, HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lagerwaard", 
        "givenName": "Frank", 
        "id": "sg:person.01126413317.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126413317.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Division of Radiation Oncology, Department of Oncology, University of Western Ontario and London Regional Cancer Program, London Health Sciences Centre,University of Western Ontario and London Regional Cancer Program, N6A4L6, London, ON, Canada", 
            "Department of Medical Biophysics, University of Western Ontario, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bauman", 
        "givenName": "Glenn", 
        "id": "sg:person.0627666704.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627666704.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.07.629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003359041"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(99)00213-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003614610"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(99)80058-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004013743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2005.05.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005827550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2005.05.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005827550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2006.11.052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010144498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(96)00619-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014462056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2005.04.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021728921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2005.04.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021728921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(89)90506-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022235183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.03.047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025173793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)16250-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038506523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(99)00198-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038891858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.06.074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040065986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-8140(03)00117-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041826131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-8140(03)00117-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041826131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2011.05.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041892439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(93)90367-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044677784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(95)02106-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046204369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(99)00340-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047679955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000245473.41035.c4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048339781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000245473.41035.c4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048339781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1118/1.1945347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053586021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(04)01933-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054653816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr/22666727", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064568490"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction with 30 Gy/10 fractions WBRT. Helical tomotherapy (HT) was found to be dosimetrically equivalent to SRS in terms of target coverage and superior to SRS in terms of normal tissue tolerance. A phase I trial has been now completed at our institution with a total of 60 enrolled patients and 48 evaluable patients. The phase II dose has been determined to be the final phase I cohort dose of 60 Gy/10 fractions.\nMETHODS/DESIGN: The objective of this clinical trial is to subject the final phase I cohort dose to a phase II assessment of the endpoints of overall survival, intracranial control (ICC) and intralesional control (ILC). We hypothesize HT would be considered unsuitable for further study if the median OS for patients treated with the HT SIB technique is degraded by 2 months, or the intracranial progression-free rates (ICC and ILC) are inferior by 10% or greater compared to the expected results with treatment by whole brain plus SRS as defined by the RTOG randomized trial. A sample size of 93 patients was calculated based on these parameters as well as the statistical assumptions of alpha = 0.025 and beta = 0.1 due to multiple statistical testing. Secondary assessments of toxicity, health-related quality-of-life, cognitive changes, and tumor response are also integrated into this research protocol.\nDISCUSSION: To summarize, the purpose of this phase II trial is to assess this non-invasive alternative to SRS in terms of central nervous system (CNS) control when compared to SRS historical controls. A follow-up phase III trial may be required depending on the results of this trial in order to definitively assess non-inferiority/superiority of this approach. Ultimately, the purpose of this line of research is to provide patients with metastatic disease to the brain a shorter course, dose intense, non-invasive radiation treatment with equivalent or improved CNS control/survival and health-related quality-of-life/toxicity profile when compared to SRS radiotherapy.\nTRIAL REGISTRATION: Clinicaltrials.gov - NCT01543542.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1748-717x-7-42", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036451", 
        "issn": [
          "1748-717X"
        ], 
        "name": "Radiation Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases", 
    "pagination": "42", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "85080aa291609bb2925c5be34eecca348a9b7fab766f9ef56e2a6809091e834e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22436144"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101265111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1748-717x-7-42"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027926222"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1748-717x-7-42", 
      "https://app.dimensions.ai/details/publication/pub.1027926222"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000537.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1748-717X-7-42"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      54 URIs      25 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1748-717x-7-42 schema:about N44c8c0cae48140f5bf9706480b7f6edb
2 N53736bacc85849bea06d389f578aa608
3 Nb1aa373f748a46afafedcb89fff8b28b
4 Nce6bd06ce8f44a628881fe9320d10bca
5 anzsrc-for:11
6 anzsrc-for:1112
7 schema:author Nbcd56747bc2948589528d4e8e112554c
8 schema:citation https://doi.org/10.1016/0360-3016(89)90506-3
9 https://doi.org/10.1016/0360-3016(93)90367-5
10 https://doi.org/10.1016/0360-3016(95)02106-x
11 https://doi.org/10.1016/j.ctrv.2005.04.007
12 https://doi.org/10.1016/j.ijrobp.2004.07.629
13 https://doi.org/10.1016/j.ijrobp.2005.05.023
14 https://doi.org/10.1016/j.ijrobp.2006.11.052
15 https://doi.org/10.1016/j.ijrobp.2007.06.074
16 https://doi.org/10.1016/j.ijrobp.2010.03.047
17 https://doi.org/10.1016/j.radonc.2011.05.032
18 https://doi.org/10.1016/s0140-6736(04)16250-8
19 https://doi.org/10.1016/s0167-8140(03)00117-8
20 https://doi.org/10.1016/s0360-3016(04)01933-9
21 https://doi.org/10.1016/s0360-3016(96)00619-0
22 https://doi.org/10.1016/s0360-3016(99)00198-4
23 https://doi.org/10.1016/s0360-3016(99)00213-8
24 https://doi.org/10.1016/s0360-3016(99)00340-5
25 https://doi.org/10.1016/s1053-4296(99)80058-7
26 https://doi.org/10.1097/01.coc.0000245473.41035.c4
27 https://doi.org/10.1118/1.1945347
28 https://doi.org/10.1259/bjr/22666727
29 schema:datePublished 2012-12
30 schema:datePublishedReg 2012-12-01
31 schema:description BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction with 30 Gy/10 fractions WBRT. Helical tomotherapy (HT) was found to be dosimetrically equivalent to SRS in terms of target coverage and superior to SRS in terms of normal tissue tolerance. A phase I trial has been now completed at our institution with a total of 60 enrolled patients and 48 evaluable patients. The phase II dose has been determined to be the final phase I cohort dose of 60 Gy/10 fractions. METHODS/DESIGN: The objective of this clinical trial is to subject the final phase I cohort dose to a phase II assessment of the endpoints of overall survival, intracranial control (ICC) and intralesional control (ILC). We hypothesize HT would be considered unsuitable for further study if the median OS for patients treated with the HT SIB technique is degraded by 2 months, or the intracranial progression-free rates (ICC and ILC) are inferior by 10% or greater compared to the expected results with treatment by whole brain plus SRS as defined by the RTOG randomized trial. A sample size of 93 patients was calculated based on these parameters as well as the statistical assumptions of alpha = 0.025 and beta = 0.1 due to multiple statistical testing. Secondary assessments of toxicity, health-related quality-of-life, cognitive changes, and tumor response are also integrated into this research protocol. DISCUSSION: To summarize, the purpose of this phase II trial is to assess this non-invasive alternative to SRS in terms of central nervous system (CNS) control when compared to SRS historical controls. A follow-up phase III trial may be required depending on the results of this trial in order to definitively assess non-inferiority/superiority of this approach. Ultimately, the purpose of this line of research is to provide patients with metastatic disease to the brain a shorter course, dose intense, non-invasive radiation treatment with equivalent or improved CNS control/survival and health-related quality-of-life/toxicity profile when compared to SRS radiotherapy. TRIAL REGISTRATION: Clinicaltrials.gov - NCT01543542.
32 schema:genre research_article
33 schema:inLanguage en
34 schema:isAccessibleForFree true
35 schema:isPartOf N4fcc82f5ee0942b6b425e934a3b613ae
36 Nbad55ee4cbe24808b62dcdbdf83eded3
37 sg:journal.1036451
38 schema:name A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases
39 schema:pagination 42
40 schema:productId N21d29fb1246b4d5c92ea765b5f5f7983
41 N3ca80b23e87e457bb62cfbd5ec7b0d7a
42 N48d1b5c270af40588f8eca9d5ed0d7a3
43 N53cdcd54ba624b82809779f10b5c5000
44 N5f0ac2968ca94922a9599713ce0c952c
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027926222
46 https://doi.org/10.1186/1748-717x-7-42
47 schema:sdDatePublished 2019-04-10T15:56
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher N5a54f339c0c9498e9e76d53067bbc3b1
50 schema:url http://link.springer.com/10.1186%2F1748-717X-7-42
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N0c7bf60df1254a4daf8bd645ceb000c6 rdf:first sg:person.01251570265.35
55 rdf:rest Nc693abbcd78f4e17b186d57b4ebec83b
56 N21d29fb1246b4d5c92ea765b5f5f7983 schema:name doi
57 schema:value 10.1186/1748-717x-7-42
58 rdf:type schema:PropertyValue
59 N3ca80b23e87e457bb62cfbd5ec7b0d7a schema:name pubmed_id
60 schema:value 22436144
61 rdf:type schema:PropertyValue
62 N3cd146f9cf34499dbd398599d1a7876a rdf:first sg:person.0627666704.37
63 rdf:rest rdf:nil
64 N44c8c0cae48140f5bf9706480b7f6edb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Cranial Irradiation
66 rdf:type schema:DefinedTerm
67 N48d1b5c270af40588f8eca9d5ed0d7a3 schema:name nlm_unique_id
68 schema:value 101265111
69 rdf:type schema:PropertyValue
70 N4fcc82f5ee0942b6b425e934a3b613ae schema:volumeNumber 7
71 rdf:type schema:PublicationVolume
72 N53736bacc85849bea06d389f578aa608 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Research Design
74 rdf:type schema:DefinedTerm
75 N53cdcd54ba624b82809779f10b5c5000 schema:name dimensions_id
76 schema:value pub.1027926222
77 rdf:type schema:PropertyValue
78 N5a54f339c0c9498e9e76d53067bbc3b1 schema:name Springer Nature - SN SciGraph project
79 rdf:type schema:Organization
80 N5f0ac2968ca94922a9599713ce0c952c schema:name readcube_id
81 schema:value 85080aa291609bb2925c5be34eecca348a9b7fab766f9ef56e2a6809091e834e
82 rdf:type schema:PropertyValue
83 N9d1d77c035a84bf4a82c4597a59c2f3b rdf:first sg:person.01002230243.29
84 rdf:rest Nf3a834ca33f44d14b29a6f24e68e8a00
85 Nb1aa373f748a46afafedcb89fff8b28b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Brain Neoplasms
87 rdf:type schema:DefinedTerm
88 Nbad55ee4cbe24808b62dcdbdf83eded3 schema:issueNumber 1
89 rdf:type schema:PublicationIssue
90 Nbcd56747bc2948589528d4e8e112554c rdf:first sg:person.0676000441.07
91 rdf:rest N9d1d77c035a84bf4a82c4597a59c2f3b
92 Nc693abbcd78f4e17b186d57b4ebec83b rdf:first sg:person.01126413317.21
93 rdf:rest N3cd146f9cf34499dbd398599d1a7876a
94 Nce6bd06ce8f44a628881fe9320d10bca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Humans
96 rdf:type schema:DefinedTerm
97 Nf3a834ca33f44d14b29a6f24e68e8a00 rdf:first sg:person.01252126745.68
98 rdf:rest N0c7bf60df1254a4daf8bd645ceb000c6
99 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
100 schema:name Medical and Health Sciences
101 rdf:type schema:DefinedTerm
102 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
103 schema:name Oncology and Carcinogenesis
104 rdf:type schema:DefinedTerm
105 sg:journal.1036451 schema:issn 1748-717X
106 schema:name Radiation Oncology
107 rdf:type schema:Periodical
108 sg:person.01002230243.29 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
109 schema:familyName Yartsev
110 schema:givenName Slav
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002230243.29
112 rdf:type schema:Person
113 sg:person.01126413317.21 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
114 schema:familyName Lagerwaard
115 schema:givenName Frank
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126413317.21
117 rdf:type schema:Person
118 sg:person.01251570265.35 schema:affiliation https://www.grid.ac/institutes/grid.25073.33
119 schema:familyName Pond
120 schema:givenName Gregory R
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251570265.35
122 rdf:type schema:Person
123 sg:person.01252126745.68 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
124 schema:familyName Tay
125 schema:givenName Keng Yeow
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252126745.68
127 rdf:type schema:Person
128 sg:person.0627666704.37 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
129 schema:familyName Bauman
130 schema:givenName Glenn
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627666704.37
132 rdf:type schema:Person
133 sg:person.0676000441.07 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
134 schema:familyName Rodrigues
135 schema:givenName George
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676000441.07
137 rdf:type schema:Person
138 https://doi.org/10.1016/0360-3016(89)90506-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022235183
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/0360-3016(93)90367-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044677784
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/0360-3016(95)02106-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046204369
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/j.ctrv.2005.04.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021728921
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1016/j.ijrobp.2004.07.629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003359041
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/j.ijrobp.2005.05.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005827550
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/j.ijrobp.2006.11.052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010144498
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/j.ijrobp.2007.06.074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040065986
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/j.ijrobp.2010.03.047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025173793
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/j.radonc.2011.05.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041892439
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/s0140-6736(04)16250-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038506523
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/s0167-8140(03)00117-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041826131
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/s0360-3016(04)01933-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054653816
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/s0360-3016(96)00619-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014462056
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s0360-3016(99)00198-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038891858
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0360-3016(99)00213-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003614610
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s0360-3016(99)00340-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047679955
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s1053-4296(99)80058-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004013743
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1097/01.coc.0000245473.41035.c4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048339781
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1118/1.1945347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053586021
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1259/bjr/22666727 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064568490
179 rdf:type schema:CreativeWork
180 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
181 schema:name Department of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081, HV Amsterdam, The Netherlands
182 rdf:type schema:Organization
183 https://www.grid.ac/institutes/grid.25073.33 schema:alternateName McMaster University
184 schema:name Department of Oncology, McMaster University and Escarpment Cancer Research Institute, L8V1C3, Hamilton, Ontario, Canada
185 rdf:type schema:Organization
186 https://www.grid.ac/institutes/grid.39381.30 schema:alternateName Western University
187 schema:name 790 Commissioners Rd. E, N6A4L6, London, ON, Canada
188 Department of Epidemiology and Biostatistics, University of Western Ontario, N6A3K7, London, ON, Canada
189 Department of Medical Biophysics, University of Western Ontario, N6A4L6, London, ON, Canada
190 Division of Radiation Oncology, Department of Oncology, University of Western Ontario and London Regional Cancer Program, London Health Sciences Centre,University of Western Ontario and London Regional Cancer Program, N6A4L6, London, ON, Canada
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.412745.1 schema:alternateName London Health Sciences Centre
193 schema:name Department of Medical Imaging, London Health Sciences Centre, N6A4L6, London, ON, Canada
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...